About Tripartite motif-containing protein 49
Tripartite motif-containing protein 49 (TRIM49) is a protein
from Homo sapiens identified by UniProt accession
P0CI25, 452 residues long.
MolForge cross-references it against 0 known binders and
11 disease associations.
Target properties
| Protein name | Tripartite motif-containing protein 49 |
| UniProt accession | P0CI25 |
| Gene | TRIM49 |
| Organism | Homo sapiens |
| Length | 452 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (11)
Diseases linked to this target (Open Targets).
- homocysteine measurement · score 0.04
- adolescent idiopathic scoliosis · score 0.03
- pulse pressure measurement · score 0.03
- sunburn · score 0.03
- soluble triggering receptor expressed on myeloid cells 2 measurement · score 0.03
- hemolytic anemia · score 0.03
- hair colour measurement · score 0.02
- forced expiratory volume · score 0.02
- HIV-1 infection · score 0.01
- Sjogren syndrome · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P0CI25-F1 | alphafold | PREDICTED | 85.44 | — |
Amino-acid sequence (452 residues)
MNSGILQVFQ GELICPLCMN YFIDPVTIDC GHSFCRPCFY LNWQDIPFLV QCSECTKSTE QINLKTNIHL KKMASLARKV SLWLFLSSEE QMCGTHRETK KIFCEVDRSL LCLLCSSSQE HRYHRHRPIE WAAEEHREKL LQKMQSLWEK ACENHRNLNV ETTRTRCWKD YVNLRLEAIR AEYQKMPAFH HEEEKHNLEM LKKKGKEIFH RLHLSKAKMA HRMEILRGMY EELNEMCHKP DVELLQAFGD ILHRSESVLL HMPQPLNPEL SAGPITGLRD RLNQFRVHIT LHHEEANNDI FLYEILRSMC IGCDHQDVPY FTATPRSFLA WGVQTFTSGK YYWEVHVGDS WNWAFGVCNM YRKEKNQNEK IDGKAGLFLL GCVKNDIQCS LFTTSPLMLQ YIPKPTSRVG LFLDCEAKTV SFVDVNQSSL IYTIPNCSFS PPLRPIFCCI HF
Explore Tripartite motif-containing protein 49 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets